ΚΙΟΡΤΣΗΣ ΔΗΜΗΤΡΙΟΣ (2011)


Papers

 Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I) a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
 Fenofibrate Reduces Systemic Inflammation Markers Independent of Its Effects on Lipid and Glucose Metabolism in Patients with the Metabolic Syndrome
 Initial conbimatin therapy with metformin and colesevelam for achievement f glycemic and lipid goals in early type 2 diabetes
 Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality collaborative analysis of 32 prospective studies
 Obesity, weight loss and conditional cardiovascular risk factors